BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19328444)

  • 1. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." "Big Asks": what can be changed to increase and speed progress on Alzheimer's disease research and treatment?
    Kukull WA
    Alzheimers Dement; 2009 Mar; 5(2):137-9. PubMed ID: 19328444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Alzheimer's disease translational research programs at the National Institute on Aging.
    Petanceska S; Ryan L; Silverberg N; Buckholtz N
    Alzheimers Dement; 2009 Mar; 5(2):130-2. PubMed ID: 19328442
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A proposal to increase participation in Alzheimer's disease clinical trials.
    Ryan JM; Schneider G; Jacobsen JS
    Alzheimers Dement; 2009 Mar; 5(2):140-2. PubMed ID: 19328445
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
    Doody RS
    Alzheimers Dement; 2009 Mar; 5(2):133-6. PubMed ID: 19328443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevent Alzheimer's disease by 2020: a national strategic goal.
    Khachaturian ZS; Khachaturian AS
    Alzheimers Dement; 2009 Mar; 5(2):81-4. PubMed ID: 19328433
    [No Abstract]   [Full Text] [Related]  

  • 6. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A national registry on aging.
    Petersen RC
    Alzheimers Dement; 2009 Mar; 5(2):105-7. PubMed ID: 19328436
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
    Gauthier S; Poirier J
    Alzheimers Dement; 2009 Mar; 5(2):147-8. PubMed ID: 19328447
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Primary prevention of dementia in Alzheimer's disease: a perspective from prevention research in cardiovascular disease and stroke.
    Fillit H; Nash DT; Shineman D
    Alzheimers Dement; 2009 Mar; 5(2):149-53. PubMed ID: 19328448
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary on "Design of comprehensive Alzheimer's disease centers to address unmet national needs".
    Sabbagh MN
    Alzheimers Dement; 2010 Mar; 6(2):156-7. PubMed ID: 20298980
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A federally funded corporation for the prevention and treatment of cognitive impairment and brain aging.
    Schneider LS
    Alzheimers Dement; 2009 Mar; 5(2):172-9. PubMed ID: 19328454
    [No Abstract]   [Full Text] [Related]  

  • 11. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Facilitating Alzheimer's disease drug development in the United States.
    Aisen PS
    Alzheimers Dement; 2009 Mar; 5(2):125-7. PubMed ID: 19328440
    [No Abstract]   [Full Text] [Related]  

  • 12. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
    Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
    Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Innovations in care that advance Alzheimer's disease drug development.
    Foster NL; Andersen TC; Zamrini EY
    Alzheimers Dement; 2009 Mar; 5(2):159-62. PubMed ID: 19328451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alzheimer's Disease Cooperative Study (ADCS)].
    Mori H; Ikeuchi T
    Brain Nerve; 2014 Jun; 66(6):691-8. PubMed ID: 24899351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." A national registry to identify a cohort for Alzheimer's disease prevention studies.
    Sabbagh MN; Tariot PN
    Alzheimers Dement; 2009 Mar; 5(2):128-9. PubMed ID: 19328441
    [No Abstract]   [Full Text] [Related]  

  • 16. Industry-sponsored clinical research: a broken system.
    Angell M
    JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigator balkanization.
    Johnston SC; Hauser SL
    Ann Neurol; 2008 Sep; 64(3):A11-2. PubMed ID: 18825670
    [No Abstract]   [Full Text] [Related]  

  • 18. What's holding us back? Understanding barriers to innovation in academic neurosurgery.
    Leuthardt EC
    Surg Neurol; 2006 Oct; 66(4):347-9; discussion 349. PubMed ID: 17015102
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Methodologic considerations for preventing Alzheimer's disease by 2020.
    Shankle WR
    Alzheimers Dement; 2010 Mar; 6(2):145-6. PubMed ID: 20298977
    [No Abstract]   [Full Text] [Related]  

  • 20. What should be done to improve the productivity of neurological research?
    Moses H; Martin JB
    Ann Neurol; 2006 Dec; 60(6):647-51. PubMed ID: 17192925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.